Interpace Biosciences Inc (IDXG)

OTC Markets
8.6900
-0.1000(-1.16%)
  • Volume:
    4,116
  • Bid/Ask:
    0.0000/0.0000
  • Day's Range:
    8.1600 - 8.6900

IDXG Overview

Prev. Close
8.6
Day's Range
8.16-8.69
Revenue
42.23M
Open
8.6
52 wk Range
2.5721-10.51
EPS
-6.12
Volume
4,116
Market Cap
35.74M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
664,875
P/E Ratio
-
Beta
1.29
1-Year Change
39.49%
Shares Outstanding
4,112,843
Next Earnings Date
Dec 01, 2021
What is your sentiment on Interpace Biosciences Inc?
or
Market is currently closed. Voting is open during market hours.

Interpace Biosciences Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellSellBuy
Technical IndicatorsSellStrong SellSellStrong SellStrong Buy
SummarySellStrong SellStrong SellStrong SellStrong Buy

Interpace Biosciences Inc Company Profile

Interpace Biosciences Inc Company Profile

Employees
152

Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. It primarily serves physicians, hospitals, and clinics. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.

Read More
  • https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
    0
    • https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
      0
      • Interpace Biosciences Announces Results of Seminal Clinical Validation Study for Thyroid Assays  -->  https://ir.interpace.com/press-releases/detail/184/interpace-biosciences-announces-results-of-seminal-clinical  --> ThyGeNEXT® + ThyraMIR® combination testing yield the highest positive predictive value (PPV) and similar negative predictive value (NPV) in comparison to other marketed tests for the same indication
        0
        • Last call to visit the $ummit
          0
          • Year to date Net Revenue was $14.6 million, a 19% increase as compared to the same period of 2019. Second quarter Net Revenue was $5.4 million   -->  https://ir.interpace.com/press-releases/detail/183/interpace-biosciences-announces-second-quarter-2020
            0
        • ThyGenX® and ThyraMIR® Data from Clinical Experience Study to be Featured at ATA Product Expo
          0
          • https://www.evicore.com/-/media/files/evicore/clinical-guidelines/solution/lab-management/healthplan/test-specific-guidelines/thyramir_and_thygenx_2020_v2.pdf
            0
          • https://onlinelibrary.wiley.com/doi/epdf/10.1002/dc.24564     --->  Huge  UP
            0
        • Any opinion....
          0
          • how big do you think this stock can get?
            0
            • Where’s this rebound
              0
              • Has been in a slump for a while bit the pull back is awesome. I expect nothing but tripple to quadrupole gains once it starts moving in the right direction.
                0
                • I'm loading up another 10k shares. Setting a limit buy at 1.70 & 1.71, 5k each... Incase I miss the 1.70. In my opinion this stock will be seeing over $2.00 today, this little dip will spark a huge buy and end the day $1.90-$2.10
                  0
                  • The soon-to-be announced next generation of ThyGenX coupled with the addition of the TERT marker will deliver a one-two punch to Veracyte's Afirma
                    0
                    • This can hit 1.54 if it breaks the 1.38 line of resistance.
                      0
                      • Hahahahahah mg booooyyyyy
                        0
                        • What a day!
                          0
                        • Yes sir felt like being in a bouncy plane
                          0
                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.